FAQ on Clene Inc.'s Participation in the Emerging Growth Conference
Summary
What is Clene Inc. presenting at the Emerging Growth Conference?
Clene Inc. will present a corporate update, focusing on its clinical-stage biopharmaceutical developments for neurodegenerative diseases, followed by a Q&A session.
When and where is the Emerging Growth Conference taking place?
The conference is scheduled for August 20, 2025, at 2:20 p.m. ET, and will be held virtually with a live webcast available on Clene’s website and through the conference registration link.
How can I access the live webcast or replays of Clene’s presentation?
The live webcast will be available through the Events section of Clene’s website and via the conference registration link, with replays accessible through the conference portal and YouTube channel.
What diseases is Clene Inc. focusing on with its treatments?
Clene Inc. is developing treatments for neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis (MS).
What is CNM-Au8(R) and what does it do?
CNM-Au8(R) is an investigational first-in-class therapy by Clene that aims to improve central nervous system cells’ survival and function by targeting mitochondrial function and the NAD pathway, while reducing oxidative stress.
Where can I find more information about Clene Inc.?
More information about Clene Inc. can be found on their website at www.clene.com or by following them on X (formerly Twitter) and LinkedIn.
Who should attend the Emerging Growth Conference session by Clene Inc.?
Investors, stakeholders, and anyone interested in biopharmaceutical developments for neurodegenerative diseases should attend to learn about Clene’s latest corporate updates and developments.
What is the significance of Clene Inc.’s presentation at the Emerging Growth Conference?
The presentation is significant as it provides insights into Clene’s progress and future directions in developing treatments for neurodegenerative diseases, potentially impacting patients and the biopharmaceutical industry.
Where is Clene Inc. based and where are its operations located?
Clene Inc. is based in Salt Lake City, Utah, with research and development (R&D) and manufacturing operations located in Maryland.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 148581